EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access · CC BY-NC-ND 4.0

When It Comes to COVID-19, Inflammation Is All the RAGE

Orestis Katsoulis, Rui Guo, Aran Singanayagam

American Journal of Respiratory Cell and Molecular Biology · 2023

DOI: 10.1165/rcmb.2023-0227ed ↗

Kurz gefasst

Editorial in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, 2023. Verfasst von Orestis Katsoulis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease Imperial College London London, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, Acute Lung Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When It Comes to COVID-19, Inflammation Is All the RAGEClinical severity caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can range from a mild self-limiting upper respiratory tract illness to severe and lifethreatening acute lung injury with requirement for intensive care (1).Hyperinflammation is a major driver of severity in coronavirus disease (COVID-19), with multiple studies to date highlighting the key role played by proinflammatory cytokines such as IL-6 and IL-1b (2).This disease feature is amenable to therapeutic inhibition using antiinflammatory approaches such as dexamethasone or tocilizumab, which have been shown to confer therapeutic benefit in clinical trials (3, 4).The nucleocapsid protein (N-protein) of SARS-CoV-2 is a putative inducer of these inflammatory pathways through activation of NF-kB, but the mechanisms leading to this activation are poorly characterized (5, 6).One potentially important upstream mediator is RAGE (receptor for advanced glycation products), a transmembrane glycoprotein highly expressed in multiple pulmonary cell types (7,8).Although the involvement of RAGE in COVID-19 pathogenesis has been postulated (9), its specific role in N-protein-induced acute lung injury has been unknown.A better understanding of the precise cellular mechanisms underlying the activation and propagation of the proinflammatory response in severe COVID-19 could have profound implications for developing more effective therapies.In this issue of the Journal, Xia and colleagues (pp.508-520) report on a study that elucidates a key role for RAGE in N-protein-mediated acute lung injury (10).Initially, the authors determined that RAGE is a receptor for N-protein through a combination of flow cytometric assays, surface plasmon resonance analysis, and demonstration that N-protein binding is attenuated in bone marrow-derived macrophages isolated from RAGE-deficient (RAGE 2/2 ) mice.A pull-down assay in mouse lung lysate was used to show that N-protein contains two different binding sites for RAGE (N-terminal domain and C-terminal domain), both of which bind to the receptor with high affinity.Having established the ligand-receptor interaction between N-protein and RAGE, the authors next interrogated the signaling cascade that begins with the binding of N-protein to RAGE and culminates in the activation of the NF-kB pathway to stimulate inflammation.Treatment of macrophages with recombinant N-protein led to phosphorylation of ERK1/2, p38 MAPK (mitogen-activated kinase), and JNK1/2, critical activators of the proinflammatory response.Importantly, inhibition of RAGE using an antagonist or through the stimulation of macrophages from RAGE 2/2 mice led to abrogated phosphorylation of ERK1/2 and NF-kB p65.Previously, the authors had demonstrated that intratracheal N-protein administration induces acute lung injury in mice (6).Here, they used this model to study the in vivo effects of RAGE in N-protein-induced acute lung injury, by showing that

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Acute Lung InjuryHumansSARS-CoV-2InflammationReceptor for Advanced Glycation End Products

Substanzen

Receptor for Advanced Glycation End Products

Autor:innen und Institutionen

  • Department of Infectious Disease Imperial College London London, United Kingdom.
  • Department of Critical Care Medicine The First Affiliated Hospital of Chongqing Medical University Chongqing, China.

Zitieren

APA

Katsoulis, O., Guo, R., & Singanayagam, A. (2023). When It Comes to COVID-19, Inflammation Is All the RAGE. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2023-0227ed

Vancouver

Katsoulis O, Guo R, Singanayagam A. When It Comes to COVID-19, Inflammation Is All the RAGE. American Journal of Respiratory Cell and Molecular Biology. 2023. doi:10.1165/rcmb.2023-0227ed

BibTeX
@article{Katsoulis2023,
  author = {Katsoulis, Orestis and Guo, Rui and Singanayagam, Aran},
  title = {When It Comes to COVID-19, Inflammation Is All the RAGE},
  journal = {American Journal of Respiratory Cell and Molecular Biology},
  year = {2023},
  doi = {10.1165/rcmb.2023-0227ed}
}
Kostenlos starten →